Haojie Jin

14PUBLICATIONS
87CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 10, 2026
H2BE113K mutation promotes breast cancer metastasis through modulating chromatin dynamics.

|Jun 26, 2026
Neoadjuvant therapy in primary liver cancer: From the missing piece to a new paradigm.

|Mar 02, 2026
A pharmacovigilance data-driven approach to reveal high fatal adverse events following checkpoint immunotherapy.

Zhen Sun, Xuan Deng, Jianglong Guo

|Mar 05, 2025
Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients.

Xiaoyi Yin, Hui Shen, Huan Wang

|Feb 06, 2025
Hepatocellular carcinoma: signaling pathways and therapeutic advances.

Jiaojiao Zheng, Siying Wang, Lei Xia

|Jan 22, 2025
Triple knockdown of CD11a, CD49d, and PSGL1 in T cells reduces CAR-T cell toxicity but preserves activity against solid tumors in mice.

Hongye Wang, Zhaorong Wu, Dan Cui

Pageof 3

Frequent Collaborators

5 joint publications

Rene Bernards

4 joint publications

Kui Ming Chan 陈居明

3 joint publications

Wenxin Qin

2 joint publications

Qi Jia